PBT
CCXI

Pictet Bank & Trust’s ChemoCentryx, Inc. CCXI Stock Holding History

Pictet Bank & Trust’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,028
Closed -$52K – 90
2016
Q1 		$52K Hold
21,028
– – 0.02% 87
2015
Q4 		$170K Hold
21,028
– – 0.06% 81
2015
Q3 		$127K Buy
+21,028
New +$152K 0.05% 114

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Pictet Bank & Trust's CCXI Position: Q2 2016 in Review

Pictet Bank & Trust sold out of ChemoCentryx, Inc. (CCXI) in Q2 2016, closing a stake of 21,028 shares — an estimated $52K sold.

Pictet Bank & Trust first reported a position in CCXI in Q3 2015 and held it in 3 quarters. The position peaked at $170K in Q4 2015. 77 funds tracked by Wall St. Rank hold CCXI as of Q2 2016.

  • Pictet Bank & Trust reported no remaining ChemoCentryx, Inc. position as of Q2 2016 after selling out during the quarter.
  • Pictet Bank & Trust sold 21,028 ChemoCentryx, Inc. shares in Q2 2016, an estimated $52K.
  • Pictet Bank & Trust first reported a position in ChemoCentryx, Inc. in Q3 2015 and held it in 3 quarters.
  • Pictet Bank & Trust's ChemoCentryx, Inc. position peaked at $170K in Q4 2015.
  • 77 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2016.

Based on Pictet Bank & Trust's 13F filing for Q2 2016, filed 10 Aug 2016.